Green Strategy to Develop Novel Drug-Containing Poly (ε-Caprolactone)-Chitosan-Silica Xerogel Hybrid Fibers for Biomedical Applications

A facile and green method was explored to prepare the tetracycline hydrochloride- (TCH-) loaded poly (ε-caprolactone)-chitosan-silica xerogel (PCL-CS-SiO2) hybrid fibers by using 90% acetic acid as a suitable solvent. The SEM results showed that those fibers exhibited a continuous, bead-free morphol...

Full description

Saved in:
Bibliographic Details
Published in:Journal of nanomaterials 2020, Vol.2020 (2020), p.1-6
Main Authors: Qian, Hai-Sheng, Zhou, Yi-Bo, Teng, Shu-Hua, Zhou, Hua-Jian
Format: Article
Language:English
Subjects:
Acetic acid
Acids
Bioceramics
Biological activity
Biomedical materials
Cell adhesion & migration
Chitosan
Contact angle
Continuous fibers
Diameters
Drug carriers
Efficiency
Fourier transforms
Morphology
Nanomaterials
Silicon dioxide
Solvents
Spectrum analysis
Thermal stability
Tissue engineering
Viscosity
Xerogels
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A facile and green method was explored to prepare the tetracycline hydrochloride- (TCH-) loaded poly (ε-caprolactone)-chitosan-silica xerogel (PCL-CS-SiO2) hybrid fibers by using 90% acetic acid as a suitable solvent. The SEM results showed that those fibers exhibited a continuous, bead-free morphology, an average diameter of about 430 nm, and super-hydrophilicity (θwater≈0°). The presence of SiO2 was found to enhance the thermal stability of the hybrid fibers, and the actual content of SiO2 was obtained by the TG measurement. Moreover, SiO2 xerogel as an important bioceramic endowed the hybrid fibers with good drug release behavior and in vitro bioactivity, suggesting their potential use as novel drug carriers for bone tissue engineering. The present work is expected to offer a green strategy to develop novel, multifunctional hybrid materials.
ISSN:1687-4110
1687-4129
DOI:10.1155/2020/6659287